The Effect of Opioid Therapy on Endocrine Function. Brennan MJ. This review summarises the major effects of opioids on the endocrine system, outlining the long-term effects of their use, which can include reduced libido and sexual function, infertility, mood disorders and bone demineralisation. Although the effects of opioids on the endocrine system are relatively common […]
Latest articles
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Two strengths of insulin now available in UK Insulin degludec (Tresiba®; Novo Nordisk, Crawley, UK) has been launched in two strengths in the UK as 100 units/mL and 200 units/mL. This 200 units/mL is […]
SHORTCUTS
Rapid response teams, do not resuscitate orders, and potential opportunities to improve end-of-life care: a multicentre retrospective study. Downar J, Rodin D, Barua R, Lejnieks B, Gudimella R, McCredie V, Hayes C, Steel A. In this retrospective review from Canada, 300 in hospital Rapid response team (RRT) consultations were reviewed in the light that […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates Routine hepatic monitoring recommended for lenalidomide The latest Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update recommends routine monitoring of hepatic function at baseline, every week for the first 8 weeks and […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Updated Controlled Drugs Regulations (Supervision of Management and Use) from 1st April 2013 Controlled Drugs (Supervision of Management and Use) Regulations 2013 (SI2103/373) for England and Scotland will come into force on 1st April […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Latest additions PCF updated monographs The online Palliative Care Formulary (PCF) is being continually updated. The following monographs have been updated during December 2012 and January 2013 and supersede those in the publication of the 4th edition […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates DTB Sativex in multiple sclerosis The latest Drug and Therapeutics Bulletin (DTB) examines the place of the cannabinoid product, Sativex (GW Pharma, UK) in multiple sclerosis. For more information click here. Glycopyrronium bromide […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Haloperidol for psychosis-induced aggression or agitation A Cochrane review has been published on the use of haloperidol for rapid tranquilisation of psychosis-induced aggression or agitation. For more information click here. BNF palliative care section updated […]
The Liverpool Care Pathway – are patients suffering unnecessarily due to media criticism?
The overwhelming majority (89%) of senior palliative care doctors who responded to a survey carried out for the BMJ and Channel 4’s Dispatches think the Liverpool care pathway (LCP) is the right approach for caring for patients in their final hours, and they would choose it for themselves. However, almost three quarters (74%) think […]
SHORTCUTS
Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Ryan NM, Birring SS, Gibson PG. This study is the first double-blind, placebo-controlled RCT to investigate gabapentin for the treatment of refractory chronic cough. In it, 62 adults with refractory chronic cough of over 2 months, who did not have active respiratory disease, were […]